Court Gives Final Nod to Settlement Of $150 Million in Flonase Antitrust Case

A $150 million settlement resolving five years of litigation over alleged misconduct by the maker of Flonase nasal spray was approved June 14 by the U.S. District Court for the Eastern District of Pennsylvania, which found the settlement to be fair, reasonable, and adequate (In re Flonase Antitrust Litigation, E.D. Pa., 2:08-cv-03149-AB, 6/14/13).

American Sales Company Inc., Meijer Inc., and Meijer Distribution Inc. brought suit against SmithKline Beecham Corporation d/b/a/ GlaxoSmithKline PLC (GSK) for allegedly violating Sherman Act §2 by delaying the entry of generic fluticasone propionate (FP)—sold by GSK under the brand name Flonase into the ...